Overall, up to 40% of all patients fail to achieve adequate biochemical response, while patients diagnosed and treated at advanced fibrosis stages, even with a complete biochemical response, have a reduced transplant-free survival compared to those diagnosed at earlier stages (36)
[1] This medication works by enhancing insulin secretion in response to meals, suppressing glucagon release, slowing gastric emptying, and reducing appetite
This is significant because leptin has its primary effects in the brain but does not cross the blood-brain barrier as readily as MT-2
Finally, source quality is everything: Contaminated peptides from gray-market suppliers are the real danger peptide users should be worried about (especially if the user improperly reconstitutes and doses them due to human error)
Patients aged 75 Years Old or Older The reduced cardiovascular and renal morbimortality associated with the use of GLP-1 RAs is beneficial for this particularly risky population [68,69,70,71,72,73]